1)Wakakura M, Mashimo K, Oono S et al:Multicenter clinical trial for evaluating methylpredonisolone pulse treatment of idiopathic optic neuritis in Japan. Jpn J Ophthalmol 43:133-138, 1999
2)Wingerchuk DM, Hogancamp WF, O'Brien PC et al:The clinical course of neuromyelitis optica(Devic syndrome). Neurology 53:1107-1114, 1999
3)Lennon VA, Kryzer TJ, Pittock SJ et al:IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 202:473-477, 2005
4)Wingerchuk DM, Lennon VA, Pittock SJ et al:Revised diagnostic criteria for neuromyelitis optica. Neurology 66:1485-1489, 2006
5)Kezuka T, Usui Y, Yamakawa N et al:Clinical relevance of the relationship between anti-aquaporin 4 antibody and anti-MOG antibody in optic neuritis. J Neuro-ophthalmol, in press
6)Ratchford JN, Quigg ME, Conger A et al:Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology 73:302-8, 2009
7)中尾雄三・山本 肇・有村英子・他:抗アクアポリン4抗体陽性視神経炎の臨床的特徴.神経眼科 25:327-342,2008
8)毛塚剛司・松永芳径・小林昭子・他:抗アクアポリン4抗体陽性視神経炎の視野変化.臨眼 64:317-322,2010
9)日本神経学会,日本神経免疫学会,日本神経治療学会(監),多発性硬化症治療ガイドライン作成委員会(編):多発性硬化症治療ガイドライン2010.医学書院,2010